By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Baltorpvej 154

Ballerup     DK-2750  Denmark
Phone: 45-70-705-225 Fax: n/a


Saniona is a research and development company focused on drugs for diseases of the central nervous system, autoimmune diseases, metabolic diseases and treatment of pain. The company has a significant portfolio of potential drug candidates at pre-clinical and clinical stage. The research is focused on ion channels, which makes up a unique protein class that enables and controls the passage of charged ions across cell membranes. Saniona has ongoing collaboration agreements with Boehringer Ingelheim GmbH, Upsher-Smith Laboratories, Inc., Productos Medix, S.A and Luc Therapeutics, Inc. Saniona is based in Copenhagen, Denmark, where it has a research center of high international standard. Saniona is listed at Nasdaq First North Premier and has about 4,500 shareholders. Pareto Securities is Certified Advisor for Saniona. The company's share is traded under the ticker SANION.




Founder and CEO: Jørgen Drejer

Founder and CFO: Thomas Feldthus

Founder and CSO: Palle Christophersen

Key Statistics

Ownership: Private

Web Site: Saniona


Company News
Saniona Reports Encouraging Start For Tesofensine Phase III Study 9/18/2017 10:42:50 AM
Saniona Presents Tesomet Phase II Data At The EASD Congress 9/12/2017 11:14:24 AM
Saniona Publishes Its Interim Report For The Second Quarter 2017 8/24/2017 6:02:55 AM
Saniona's Partner, Productos Medix, S.A de S.V, Initiates Phase III Study For Tesofensine In Obesity 8/21/2017 10:18:08 AM
Saniona's Partner, Luc Therapeutics, Nominates Clinical Candidate And Initiates Preclinical Development In Joint Ataxia Program 8/14/2017 8:50:40 AM
Saniona Buys Out Payment Obligation To Neurosearch A/S (NEUR.CO) 7/5/2017 11:00:17 AM
Saniona Approved For Listing On Nasdaq Stockholm's Main Market 5/31/2017 10:15:05 AM
Bulletin From The Annual Shareholders' Meeting On May 23, 2017 In Saniona 5/23/2017 10:19:10 AM
Saniona Publishes Its Interim Report For The First Quarter 2017 5/11/2017 12:43:56 PM
Saniona's Renames The Upsher-Smith Laboratories Program To Proxima Program 4/28/2017 11:03:06 AM